期刊文献+

心力衰竭患者血浆细胞因子变化与心功能的关系 被引量:5

Relationship between plasma cytokine changes and cardiac function in patients with heart failure
暂未订购
导出
摘要 目的:分析心力衰竭患者血浆细胞因子变化与心功能的关系。方法:选择2011年8月至2013年8月我院收治的58例心力衰竭患者为心衰组,另选同期来我院进行体检的58名健康人群作为健康对照组,运用酶联免疫吸附试验(ELISA)检测其C反应蛋白(CRP)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、Th1/Th2细胞因子干扰素-γ(IFN-γ)、白介素-4(IL-4)水平,并进行比较。结果:与健康对照组比较,心衰组NYHAⅡ级、NYHAⅢ级、Ⅳ级患者的CRP[(3.57±1.15)mg/L比(6.21±1.89)mg/L、(6.89±2.02)mg/L、(7.57±2.11)mg/L]、TNF-α[(4.31±2.09)ng/L比(13.97±3.24)ng/L、(16.23±3.59)ng/L、(18.55±3.61)ng/L]、IL-6[(8.25±1.2)ng/L比(19.27±4.26)ng/L、(25.78±4.89)ng/L、(34.44±6.12)ng/L]水平均明显升高;外周血IFN-γ水平[(48.21±7.52)pg/ml比(68.63±8.24)pg/ml、(73.91±10.14)pg/ml、(82.44±11.58)pg/ml]、IFN-γ/IL-4[(1.07±0.12)比(1.73±1.26)、(2.09±1.31)、(2.38±1.40)]均显著升高(P均<0.05);NYHAⅢ级、Ⅳ级患者的外周血IL-4[(45.11±6.97)pgl/ml比(35.31±5.47)pgl/ml、(34.56±4.92)pgl/ml]水平显著降低(P均<0.05)。NYHAⅢ级、Ⅳ级患者的外周血IFN-γ、IFN-γ/IL-4显著高于NYHAⅡ级组患者,且NYHAⅣ级组患者又显著高于Ⅲ级组的(P均<0.05)。结论:心力衰竭患者血浆细胞因子与心功能密切相关。 Objective: To analyze the relationship between plasma cytokine changes and cardiac function in patients with heart failure. Methods: A total of 58 patients with heart failure treated in our hospital from Aug 2011 to Aug 2013 were selected as heart failure group, another 58 healthy people undergoing physical examination in our hospital during the same period were regarded as healthy control group. Enzyme linked immunosorbent assay (ELISA) was used to measure levels of C reactive protein (CRP), interleukin- 6 (IL-6), tumor necrosis factor - a (TNF-a), Thl/Th2 cytokine interferon- 7 (IFN-7) and interleukin- 4 (IL-4), and the results were compared between two groups. Results: Compared with healthy control group, there were significant rise in levels of CRP [ (3.57±1.15) mg/Lvs. (6. 21±1.89) mg/L, (6. 89±2.02) rag/L, (7.57±2.11) mg/L], TNF-a [ (4. 31±2.09) ng/L vs. (13.97± 3.24) ng/L, (16. 23 ± 3.59) ng/L, (18.55 ± 3.61) ng/L] and IL-6 [(8. 25± 1.2) ng/L vs. (19. 27±4.26) ng/L, (25.78± 4.89) ng/L, (34. 44± 6. 12) ng/L] and significant increase in peripheral blood levels of IFN-7 [- (48.21± 7.52) pg/ml vs. (68. 63 ± 8.24) pg/ml, (73.91± 10.14) pg/ml, (82.44 ± 11.58) pg/ml] and IFN-7/IL- 4 [ (1.07±0.12) vs. (1.73±1.26), (2.09±1.31), (2.38±1.40)] in patients with NYHAclass ]1, Ⅲ and 1V from heart failure group (P〈0. 05 all) ; and significant reduction in peripheral level of IL-4 (45. 11± 6.97) pgl/ ml vs. (35.31± 5.47) pgl/ml, (34.56± 4.92) pgl/ml] in patients with NYHA class Ⅲ and IV, P〈0.05 both. The IFN-7 and IFN-7/IL-4 levels in patients with NYHA class Ⅲ and Ⅳ were significant higher than those of NYHA class Ⅲ , and those of NYHA class IV group were significant higher than those of NYHA class Ⅲ group, P〈0.05 all. Conclusion: Plasma cytokine levels are closely related to cardiac function in patients with heart failure.
作者 苗永国
出处 《心血管康复医学杂志》 CAS 2015年第4期373-376,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 心力衰竭 细胞因子类 心室功能 Heart failure Cytokines Ventricular function
  • 相关文献

参考文献13

二级参考文献92

共引文献96

同被引文献45

  • 1虞华鹏,高成志,孙玲,马圣庭.重组人脑利钠肽治疗急性心肌梗死伴心衰患者124例临床效果[J].中国急救医学,2017,37(A01):198-199. 被引量:5
  • 2Nagaya N,Miyatake K,Uematsu M,et al.Hemodynamic,renal,and hormonal effects of ghrelin infusion in patients with chronic heart failure[J].J Clin Endocrinol Metab,2001,86(12):5854-5859.
  • 3Nagaya N,Kangawa K.Therapeutic potential of ghrelin in the treatment of heart failure[J].Drugs,2006,66(4):439-448.
  • 4Nagaya N,Kojima M,Uematsu M,et al.Hemodynamic and hormonal effects of human ghrelin in healthy volunteers[J].Am J Physiol Regul Integr Comp Physiol,2001,280(5):1483-1487.
  • 5Nagaya N,Kangawa K.Ghrelin,a novel growth hormonereleasing petide,in the treatment of chronic heart failure[J].Regul Pept,2003,114(2-3):71-77.
  • 6Nagaya N,Uematsu M,Kojima M,et al.Elevated circulating level of ghrelin in cachexia associated with chronic heart failure:relationships between ghrelin and anabolic/catabolic factors[J].Circulation,2001,104(17):2034-2038.
  • 7Xu J P,Wang H X,Wang W,et al.Ghrelin improves disturbed myocardial energy metabolism in rats with heart failure induced by isoproterenol[J].J Pept Sci,2010,16(8):392-402.
  • 8Torre-Amione G.Immune activation in chronic heart failure[J].Am J Cardiol,2005,95(10):3-8.
  • 9Celis R,Torre-Martinez G,Torre-Amione G.Evidence for activation of immune system in heart failure:is there a role for anti-inflammatory therapy[J].Curropin Cardiol,2008,23(3):254-260.
  • 10Yamaoka-Tojo M,Tojo T,Inomata T,et al.Circulating levels of interleukin18 reflect etiologies of heart failure:Th1/Th2cytokine imbalance exaggerates the pathophysiology of advanced heart failure[J].J Card Fail,2002,8(1):21-27.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部